Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBBM-S1 versus autologous bone graft in lumbar interbody fusion
jRCT2031250569Phase 2Recruiting
- Sponsor
- ORTHOREBIRTH
- Start
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of ReBOSSIS in lumbar spinal stenosis (LSS), degenerative spondylolisthesis (DS), lumbar spondylolysis and 4 more (2 arms), sponsored by ORTHOREBIRTH. Started Dec 2025; status: recruiting.
02
Drugs
ReBOSSIS
03
Conditions
lumbar spinal stenosis (LSS)degenerative spondylolisthesis (DS)lumbar spondylolysislumbar spondylolisthesisdegenerative scoliosis
Beyond the preview
Go deeper on jRCT2031250569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250569.